AYRO to Report Second Quarter 2022 Financial Results on August 11, 2022 and Provide Corporate Update
August 04, 2022 08:00 ET
|
AYRO, Inc.
Conference Call to be held on Thursday, August 11, 2022 at 8:30 a.m. Eastern Time ROUND ROCK, TX, Aug. 04, 2022 (GLOBE NEWSWIRE) -- AYRO, Inc. (Nasdaq: AYRO) (“AYRO” or the “Company”), a...
Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
July 28, 2022 08:00 ET
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, July 28, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
ObsEva Announces Corporate Updates
July 27, 2022 07:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
ObsEva Announces Corporate Updates
July 27, 2022 01:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel...
Standard Lithium Corporate Update
July 13, 2022 06:30 ET
|
Standard Lithium
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and...
Tactical Resources Provides Corporate Update
June 07, 2022 08:30 ET
|
Tactical Resources Corp.
VANCOUVER, British Columbia, June 07, 2022 (GLOBE NEWSWIRE) -- Tactical Resources Corp. (CSE: RARE) (“Tactical Resources” or the “Company”), a mineral exploration and development company focused on...
Verus Signs Joint Venture with Flörd, Provides Corporate Update
June 01, 2022 09:00 ET
|
Verus International, Inc.
Orlando, FL, June 01, 2022 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS), a food and hemp-based products company, is pleased to announce that it has...
ObsEva Announces Corporate Updates
May 27, 2022 16:01 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update
May 17, 2022 07:00 ET
|
ObsEva SA
-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis:...
ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update
May 17, 2022 01:00 ET
|
ObsEva SA
-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis:...